We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Pathway Outlined that Regulates Centrosome Disassociation During Cell Division

By LabMedica International staff writers
Posted on 08 Dec 2010
The detailed structure of a molecular pathway controlling the disassociation of the centrosome during cell division has been revealed in a recent publication.

During interphase, centrosomes are held together by a proteinaceous linker that connects the proximal ends of the mother and daughter centrioles. More...
This linker is disassembled at the onset of mitosis in a process known as centrosome disjunction, thereby facilitating centrosome separation and bipolar spindle formation. An enzyme known as NIMA (never in mitosis A)-related kinase or Nek2A has been implicated in disconnecting the centrosomes through disjoining the linker proteins C-Nap1 and rootletin. However, the mechanisms controlling centrosome disjunction have remained poorly understood.

In the current study, which appeared in the November 14, 2010, online edition of the journal Nature Cell Biology, investigators at the University of Heidelberg (Germany) and the University of Leicester (United Kingdom) explained how Nek2A directly interacted with two Hippo pathway components, the mammalian sterile 20-like kinase 2 (Mst2) and the scaffold protein Salvador (hSav1). This interaction regulated the ability of Nek2A to localize to centrosomes and phosphorylate the linker proteins C-Nap1 and rootletin.

Contributing author Dr. Andrew Fry, professor of biochemistry at the University of Leicester, said, "This is an exciting new development that offers potential for finding new ways of inhibiting unregulated cell division which is a characteristic of cancer. Our research has identified new proteins that control centrosome separation as well as assessing the relative contributions of these together with previously described regulators. Importantly, this work suggests exciting new approaches to the targeted treatment of diseases characterized by deregulated cell division, such as cancer, as inhibitors of centrosome separation have the potential to prevent uncontrolled cell proliferation.”

Related Links:
University of Heidelberg
University of Leicester



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.